0001415889-21-000970.txt : 20210225
0001415889-21-000970.hdr.sgml : 20210225
20210225200208
ACCESSION NUMBER: 0001415889-21-000970
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210223
FILED AS OF DATE: 20210225
DATE AS OF CHANGE: 20210225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sheena Jonathan
CENTRAL INDEX KEY: 0001646649
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 21682894
MAIL ADDRESS:
STREET 1: C/O NATERA, INC.
STREET 2: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
form4-02252021_050256.xml
X0306
4
2021-02-23
0001604821
Natera, Inc.
NTRA
0001646649
Sheena Jonathan
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
AUSTIN
TX
78753
true
true
false
false
CO-FOUNDER
Common Stock
2021-02-23
4
A
0
3225
0
A
436085
D
Common Stock
2021-02-24
4
M
0
10000
1.141
A
446085
D
Common Stock
2021-02-25
4
S
0
1038
106.6918
D
445047
D
Stock Option (right to buy)
1.141
2021-02-24
4
M
0
10000
0
D
2022-09-20
Common Stock
10000
126950
D
On April 12, 2019, the Reporting Person was granted a performance-based Restricted Stock Units (the "RSUs") covering 6,450 shares of common stock, which vests in tranches upon the Issuer achieving certain specified financial and operating metrics. On February 23, 2021, the milestones were satisfied for the vesting of RSUs covering 3,225 shares of common stock.
The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs pursuant to Rule 10b5-1.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.68 o $106.9112 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option shares are fully vested and may be exercised at any time.
/s/ Tami Chen, Attorney-in-Fact
2021-02-25